<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: <z:chebi fb="0" ids="16443,47693,49088">D-Tagatose</z:chebi> (<z:chebi fb="0" ids="16443">D-tag</z:chebi>), a <z:chebi fb="0" ids="18133">hexose</z:chebi> bulk sweetener, does not affect plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels when orally administered to rodents </plain></SENT>
<SENT sid="1" pm="."><plain>Additionally, <z:chebi fb="0" ids="16443">D-tag</z:chebi> attenuates the rise in plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> after mice are administered oral <z:chebi fb="27" ids="17992">sucrose</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The current study was undertaken to investigate the <z:hpo ids='HP_0011009'>acute</z:hpo> glycaemic effects of oral <z:chebi fb="0" ids="16443">D-tag</z:chebi> alone or in combination with oral <z:chebi fb="105" ids="17234">glucose</z:chebi> in human subjects with and without type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Glycaemic responses to <z:chebi fb="0" ids="16443">D-tag</z:chebi> also were investigated in subjects after oral <z:chebi fb="27" ids="17992">sucrose</z:chebi> to examine whether the <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering effects of <z:chebi fb="0" ids="16443">D-tag</z:chebi> in rodents may result from a direct inhibition of intestinal disaccharidases </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Eight <z:mpath ids='MPATH_458'>normal</z:mpath> and eight subjects with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> were administered 75 g of <z:chebi fb="105" ids="17234">glucose</z:chebi>, 75 g of <z:chebi fb="0" ids="16443">D-tag</z:chebi>, or 75 g of <z:chebi fb="0" ids="16443">D-tag</z:chebi> 30 min prior to a 75 g oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) </plain></SENT>
<SENT sid="5" pm="."><plain>Five patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> were challenged with a 75 g oral <z:chebi fb="27" ids="17992">sucrose</z:chebi> tolerance test (OSTT) with and without oral pre-treatment with 75 g of <z:chebi fb="0" ids="16443">D-tag</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> also received separate 0, 10, 15, 20 and 30 g of <z:chebi fb="0" ids="16443">D-tag</z:chebi> 30 min prior to a 75 g OGTT </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Oral loading with <z:chebi fb="0" ids="16443">D-tag</z:chebi> alone led to no changes in <z:chebi fb="105" ids="17234">glucose</z:chebi> or insulin levels in either <z:mpath ids='MPATH_458'>normal</z:mpath> patients or those with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Pre-OGTT treatment with 75 g <z:chebi fb="0" ids="16443">D-tag</z:chebi>, however, attenuated the rise in <z:chebi fb="105" ids="17234">glucose</z:chebi> levels in patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (p &lt; 0.02 at 60 and 180 min, and p &lt; 0.01 at 120 min) </plain></SENT>
<SENT sid="9" pm="."><plain>The <z:chebi fb="105" ids="17234">glucose</z:chebi> area under the curve (AUC) was reduced significantly also by pre-treatment with <z:chebi fb="0" ids="16443">D-tag</z:chebi> in a dose-dependent manner in patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (p &lt; 0.05 for 10 g <z:chebi fb="0" ids="16443">D-tag</z:chebi>, p &lt; 0.001 for 20 g <z:chebi fb="0" ids="16443">D-tag</z:chebi>, and p = 0.0001 for 30 g <z:chebi fb="0" ids="16443">D-tag</z:chebi>) </plain></SENT>
<SENT sid="10" pm="."><plain>In patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> 75 g <z:chebi fb="0" ids="16443">D-tag</z:chebi> similarly attenuated the rise in <z:chebi fb="105" ids="17234">glucose</z:chebi> following an OSTT (p &lt; 0.01 at 30 min, and p &lt; 0.02 at 60 min) </plain></SENT>
<SENT sid="11" pm="."><plain>Pre-treatment with 75 g <z:chebi fb="0" ids="16443">D-tag</z:chebi> also tended to blunt the rise in insulin following an OGTT in <z:mpath ids='MPATH_458'>normal</z:mpath> patients (p = 0.07 for insulin AUC) but not patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (p = 0.66) </plain></SENT>
<SENT sid="12" pm="."><plain>Following 75 g of oral <z:chebi fb="0" ids="16443">D-tag</z:chebi> in four <z:mpath ids='MPATH_458'>normal</z:mpath> patients, plasma <z:chebi fb="0" ids="16443">D-tag</z:chebi> levels rose to a mean peak level of 3.6 mg/dl at 90 min </plain></SENT>
<SENT sid="13" pm="."><plain>The administration of 75 g <z:chebi fb="0" ids="16443">D-tag</z:chebi> led to diarrhoea, <z:hpo ids='HP_0002018'>nausea</z:hpo> and/or flatulence in 100% of subjects </plain></SENT>
<SENT sid="14" pm="."><plain>When <z:chebi fb="0" ids="16443">D-tag</z:chebi> was administered at lower doses ranging from 10 g to 30 g, only three of 10 patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> had gastrointestinal symptoms which were much more mild than those evoked by 75 g <z:chebi fb="0" ids="16443">D-tag</z:chebi> </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSIONS: These results show that oral <z:chebi fb="0" ids="16443">D-tag</z:chebi> significantly blunts the rise in plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> seen after oral <z:chebi fb="105" ids="17234">glucose</z:chebi> in patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> in a dose-dependent manner without significantly affecting insulin levels </plain></SENT>
<SENT sid="16" pm="."><plain>The minimal elevation of plasma <z:chebi fb="0" ids="16443">D-tag</z:chebi> levels in <z:mpath ids='MPATH_458'>normal</z:mpath> patients and the adverse gastrointestinal effects seen following larger doses of <z:chebi fb="0" ids="16443">D-tag</z:chebi> support poor absorption of this <z:chebi fb="0" ids="18133">hexose</z:chebi> and suggest that <z:chebi fb="0" ids="16443">D-tag</z:chebi> may act by attenuating <z:chebi fb="105" ids="17234">glucose</z:chebi> absorption in the intestine </plain></SENT>
<SENT sid="17" pm="."><plain><z:chebi fb="0" ids="16443">D-tag</z:chebi> may be a useful therapeutic adjunct in the management of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
</text></document>